Black Diamond Therapeutics I

Penny Stocks Biotech Stocks Healthcare Stocks

$2.99

+0.27 (+9.93%)

As of May 16, 2:11 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,101.3% upside

Low Target $30.62

Average Target $35.92

High Target $44.24

Current Price $2.99

Current
$2.99

Target
$35.92

$30.62 $35.92 avg $44.24

Scenario Analysis

Bear Case

$30.62

924.1%

Low target

Base Case

$35.92

+1,101.3%

Avg target

Bull Case

$44.24

+1,379.6%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$4.94

-39.5% from high

52-Week Low

$1.77

+68.9% from low

Target vs 52W High

$35.92

+627.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%